{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:54:54Z","timestamp":1778172894590,"version":"3.51.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Rett Syndrome (RTT) is an X-linked progressive disease affecting 1 in 10,000 females. <jats:italic>MECP2<\/jats:italic> p.R133C, is the second most common variant affecting more than 4% of all RTT cases. <jats:italic>GABBR1<\/jats:italic> pathogenic variants have been recently associated with mild to severe psychomotor delay, epilepsy, intellectual disability (ID), autism (ASD), attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>We report a 13.9-year-old girl, with a complex neurodevelopmental disorder including ASD, ID with the appearance, at 9 years of age, of vocal and motor tics involving the upper limbs and trunk, suggesting a diagnosis of Tourette's syndrome (TS). Tics were also present in the mother and grandmother. The patient was followed-up for approximately 10 years and underwent periodic clinical and neuropsychological evaluations. We performed Trio-based WES analysis and segregation analysis in relevant family members.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A <jats:italic>de novo MECP2<\/jats:italic> variant (p. R133C) was detected in the proband. Moreover, a maternally inherited VoUS class 3 in <jats:italic>GABBR1<\/jats:italic> (p. F692S), was identified in the proband, and segregated in the mother and grandmother. No functional studies confirm the pathogenicity of this <jats:italic>GABBR1<\/jats:italic> variant, and Tourette phenotypes have not been previously linked to <jats:italic>GABBR1<\/jats:italic>. Based on familial segregation, we hypothesize that this variant may worsen the <jats:italic>MECP2<\/jats:italic>-related phenotype and underlie the Tourette symptoms seen in all carriers. Tourette phenotypes have never been reported with <jats:italic>MECP2<\/jats:italic> variants alone. Although Rett-like features are mainly due to <jats:italic>MECP2<\/jats:italic> loss-of-function, <jats:italic>MECP2<\/jats:italic> deficiency disrupts GABAergic signaling, making GABA modulators potential therapeutic targets. The presence of the <jats:italic>GABBR1<\/jats:italic> variant may further impair GABA receptor neurotransmission. Thus, the <jats:italic>GABBR1<\/jats:italic> variant may be a modifying factor in this case, though its pathogenicity remains uncertain. Despite attempts to manage her condition with appropriate pharmacological therapies, progressive muscle hypertonia and behavioral issues, persisted. The patient showed improvements in engagement and emotional regulation, during music therapy sessions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We describe the developmental trajectory of an adolescent with overlapping features of Rett and Tourette syndromes, carrying <jats:italic>MECP2<\/jats:italic> and <jats:italic>GABBR1<\/jats:italic> variants. Future studies are essential to better characterize the genotype-phenotype correlates and optimize therapeutic strategies, to tackle the unique needs of the patient and her family.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1617479","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:30:52Z","timestamp":1750311052000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Diagnostic assessment, developmental trajectory and treatment approaches in a case of a complex neurodevelopmental syndrome associated with non- synonymous variants in MECP2 (p. R133C) and GABBR1"],"prefix":"10.3389","volume":"13","author":[{"given":"V.","family":"Napoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guerrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Demaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cianfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Passarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Logrieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vicari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","volume-title":"Publication Manual of the American Psychological Association","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J Med Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"52e","DOI":"10.1136\/jmg.40.5.e52","article-title":"Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations?","volume":"40","author":"Leonard","year":"2003","journal-title":"J Med Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.braindev.2008.04.007","article-title":"Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant)","volume":"31","author":"Renieri","year":"2009","journal-title":"Brain Dev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mds.26089","article-title":"Population prevalence of Tourette syndrome: a systematic review and meta-analysis","volume":"30","author":"Scharf","year":"2015","journal-title":"Mov Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jocrd.2014.03.004","article-title":"Clinical features of tourette syndrome and tic disorders","volume":"3","author":"Leckman","year":"2014","journal-title":"J Obsessive-Compuls Relat Disord."},{"key":"B9","article-title":"Griffiths Mental Development Scales - Extended Revised: Two to Eight Years (GMDS-ER).","author":"Luiz","year":"2009"},{"key":"B10","article-title":"Leiter International Performance Scale","author":"Roid","year":"2013"},{"key":"B11","article-title":"Leiter International Performance Scale - 3rd ed.: Italian adaptation [Leiter 3]","author":"Cornoldi","year":"2015"},{"key":"B12","article-title":"ABAS-II - Adaptive Behavior Assessment System - Seconda Edizione - Edizione Italiana","author":"Ferri","year":"2011"},{"key":"B13","article-title":"Il primo vocabolario del bambino: Guida all\u2019uso del questionario MacArthur-Bates Communicative Development Inventories","author":"Caselli","year":"2006"},{"key":"B14","author":"Vicari","year":"2007","journal-title":"TFL Test Fono-lessicale. Valutazione delle abilit\u00e0 lessicali in et\u00e0 prescolare"},{"key":"B15","article-title":"Autism Diagnostic Observation Schedule, 2nd ed. (ADOS-2)","author":"Lord","year":"2015"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/0022-006X.55.1.3","article-title":"Behavioral treatment and normal educational and intellectual functioning in young autistic children","volume":"55","author":"Lovaas","year":"1987","journal-title":"J Consult Clin Psychol"},{"key":"B17","first-page":"512","article-title":"The Child with Special Needs: Encouraging Intellectual and Emotional Growth","author":"Greenspan","year":"1998"},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40474-013-0007-x","article-title":"Augmentative and alternative communication for individuals with autism Spectrum disorder and intellectual disability","volume":"1","author":"Sigafoos","year":"2014","journal-title":"Curr Dev Disord Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/17518423.2011.575438","article-title":"Group swimming and aquatic exercise programme for children with autism spectrum disorders: a pilot study","volume":"14","author":"Fragala-Pinkham","year":"2011","journal-title":"Dev Neurorehabil"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajmg.10005","article-title":"Preserved speech variants of the Rett syndrome: molecular and clinical analysis","volume":"104","author":"Zappella","year":"2001","journal-title":"Am J Med Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/hmg\/9.7.1119","article-title":"Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location","volume":"9","author":"Cheadle","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13023-016-0499-7","article-title":"Rett syndrome: a wide clinical and autonomic picture","volume":"11","author":"Pini","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1152\/jn.00060.2015","article-title":"Reduced GABAergic inhibition and abnormal sensory symptoms in children with Tourette syndrome","volume":"114","author":"Puts","year":"2015","journal-title":"J Neurophysiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1469-8749.2012.04123.x","article-title":"Early speech\u2013language development in females with Rett syndrome: focusing on the preserved speech variant","volume":"54","author":"Marschik","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1023\/A:1026052128305","article-title":"The preserved speech variant: a subgroup of the Rett complex: a clinical report of 30 cases","volume":"28","author":"Zappella","year":"1998","journal-title":"J Autism Dev Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000337637","article-title":"Rett syndrome","volume":"2","author":"Smeets","year":"2011","journal-title":"Mol Syndromol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.braindev.2018.08.008","article-title":"Behavioral profiles in Rett syndrome: data from the natural history study","volume":"41","author":"Buchanan","year":"2019","journal-title":"Brain Dev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjpo-2020-000717","article-title":"Consensus guidelines on managing Rett syndrome across the lifespan","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2023.4003","article-title":"Trofinetide receives FDA approval as first drug for Rett syndrome","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"B30","first-page":"391","article-title":"The psychopharmacology of autism spectrum disorder and Rett syndrome","volume-title":"Handbook of Clinical Neurology","author":"Persico","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.ajhg.2022.08.010","article-title":"GABBR1 Monoallelic de novo variants linked to neurodevelopmental delay and epilepsy","volume":"109","author":"Cediel","year":"2022","journal-title":"Am J Hum Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10882-009-9168-2","article-title":"Communication in individuals with Rett syndrome: an assessment of forms and functions","volume":"22","author":"Didden","year":"2010","journal-title":"J Dev Phys Disabil."},{"key":"B33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/17518423.2013.783139","article-title":"Developmental profile of speech-language and communicative functions in an individual with the preserved speech variant of Rett syndrome","volume":"17","author":"Marschik","year":"2014","journal-title":"Dev Neurorehabilitation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10578-022-01390-z","article-title":"Using the Griffiths mental development scales to evaluate a developmental profile of children with autism spectrum disorder and their symptomatologic severity","volume":"55","author":"Pino","year":"2024","journal-title":"Child Psychiatry Hum Dev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1617479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:30:54Z","timestamp":1750311054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1617479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":35,"alternative-id":["10.3389\/fped.2025.1617479"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1617479","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1617479"}}